Glaukos Announces Participation in J.P. Morgan Healthcare Conference

by Business Wire • 2016/12/21 • 0 Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017, at 10:00 a.m. PST in San Francisco. A live audio webcast for this event will be available in the I

← GenSight reports visual acuity gains in phase 1/2 study of GS010 for Leber’s hereditary optic neuropathy

Diabetic Macular Edema Market: By Type, Treatment Categories & Geography – With Forecast (2016-2021) – Research and Markets →

Post navigation